Grufity logoGrufity logo
StocksFundsSearch Filings

CorVel Corp Stock Research

CRVL

204.04USD-1.33(-0.65%)Market Closed

Market Summary

USD204.04-1.33
Market Closed
-0.65%

CRVL Stock Price

CRVL RSI Chart

CRVL Valuation

Market Cap

3.5B

Price/Earnings (Trailing)

52.01

Price/Sales (Trailing)

5.01

EV/EBITDA

30.51

Price/Free Cashflow

63.24

CRVL Price/Sales (Trailing)

CRVL Profitability

EBT Margin

12.52%

Return on Equity

34.82%

Return on Assets

16.64%

Free Cashflow Yield

1.58%

CRVL Fundamentals

CRVL Revenue

Revenue (TTM)

704.5M

Revenue Y/Y

9.04%

Revenue Q/Q

1.1%

CRVL Earnings

Earnings (TTM)

67.8M

Earnings Y/Y

21.58%

Earnings Q/Q

14.96%

Price Action

52 Week Range

129.19221.82
(Low)(High)

Last 7 days

-6.3%

Last 30 days

3.7%

Last 90 days

11.5%

Trailing 12 Months

37.4%

CRVL Financial Health

Current Ratio

1.38

CRVL Investor Care

Buy Backs (1Y)

3.40%

Diluted EPS (TTM)

3.82

Peers (Alternatives to CorVel)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
446.3B
335.9B
-1.52% 1.40%
21.55
1.33
12.90% 18.65%
91.1B
183.0B
-0.38% 0.92%
13.64
1.92
3.34% 24.58%
65.7B
95.6B
4.18% 19.07%
23.41
0.71
10.74% 2.64%
36.1B
146.3B
-2.07% -20.86%
24.33
0.25
9.81% -0.94%
MID-CAP
5.2B
2.3B
3.17% 35.63%
86.23
2.28
2.85% -58.05%
4.8B
861.7M
-1.68% -3.80%
-184.05
5.58
13.90% 40.97%
3.9B
4.8B
10.30% 10.74%
10.14
0.81
3.57% -4.88%
3.5B
704.5M
3.68% 37.43%
52.01
5.01
13.56% 10.15%
2.6B
6.4B
2.08% -10.17%
13.51
0.41
-0.52% 16.73%
SMALL-CAP
1.7B
1.5B
3.86% 49.24%
-124.46
1.12
10.24% -173.11%
1.4B
976.1M
-19.00% 6.62%
28.58
1.47
10.19% 12.37%
692.7M
2.9B
-12.80% -32.97%
-3.79
0.24
7.97% -101.02%

Financials for CorVel

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue2.2%704690670646620
Gross Profit3.3%159154155152145
  S&GA Expenses0.9%71.0071.0070.0068.0067.00
EBITDA4.3%113108109108-
EBITDA Margin2.1%0.16*0.16*0.16*0.17*-
Earnings Before Taxes5.4%88.0084.0085.0085.0078.00
EBT Margin3.2%0.13*0.12*0.13*0.13*-
Net Income4.6%68.0065.0066.0066.0062.00
Net Income Margin2.4%0.10*0.09*0.10*0.10*-
Free Cahsflow38.8%56.0040.0051.0037.00-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets2.0%408400416415424
  Current Assets3.4%257248261265269
    Cash Equivalents3.2%78.0076.0094.0098.00116
  Net PPE-0.5%82.0083.0084.0076.0071.00
  Goodwill0%37.0037.0037.0037.0037.00
Liabilities5.4%213202210203209
  Current Liabilities6.2%186176181171171
Shareholder's Equity-1.5%195198206212215
  Retained Earnings2.4%713697682665646
  Additional Paid-In Capital1.4%211208205202199
Accumulated Depreciation-208----
Shares Outstanding-0.8%17.0017.0017.0018.0018.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations20.3%86.0072.0083.0067.0071.00
  Share Based Compensation10.7%5.005.005.005.005.00
Cashflow From Investing3.3%-30.54-31.60-31.74-29.82-22.39
Cashflow From Financing2.4%-93.30-95.63-95.40-79.61-61.91
  Buy Backs-2.7%10010310390.0076.00

Risks for CRVL

What is the probability of a big loss on CRVL?

51.9%


Probability that CorVel stock will be more than 20% underwater in next one year

30%


Probability that CorVel stock will be more than 30% underwater in next one year.

17.7%


Probability that CorVel stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CRVL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CorVel was unfortunately bought at previous high price.

Drawdowns

Returns for CRVL

Cumulative Returns on CRVL

23.6%


10-Year Cumulative Returns

23.5%


7-Year Cumulative Returns

31.2%


5-Year Cumulative Returns

55.4%


3-Year Cumulative Returns

What are the long-term rolling returns for CRVL?

FIve years rolling returns for CorVel.

Annualized Returns

Which funds bought or sold CRVL recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-05-18
JPMORGAN CHASE & CO
added
20.46
1,090,000
2,976,000
-%
2023-05-18
NEW YORK STATE COMMON RETIREMENT FUND
reduced
-32.35
-113,000
875,000
-%
2023-05-18
SkyView Investment Advisors, LLC
added
13.58
224,000
683,000
0.16%
2023-05-17
KB FINANCIAL PARTNERS, LLC
added
11.81
199,000
627,000
0.18%
2023-05-17
Thrivent Financial for Lutherans
reduced
-3.97
351,000
1,715,000
-%
2023-05-16
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
added
3.91
99,674,800
376,139,000
1.11%
2023-05-16
Rockefeller Capital Management L.P.
sold off
-100
-
-
-%
2023-05-16
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
unchanged
-
266,643
1,128,740
0.03%
2023-05-16
SUSQUEHANNA INTERNATIONAL GROUP, LLP
new
-
2,053,310
2,053,310
-%
2023-05-16
RBF Capital, LLC
unchanged
-
89,560
380,560
0.03%

1–10 of 45

Latest Funds Activity

Are funds buying CRVL calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CRVL
No. of Funds

CorVel News

Best Stocks
Raymond James & Associates reduces stake in CorVel Co. amidst ....
Best Stocks,
13 minutes ago
Simply Wall St
Investor's Business Daily

Schedule 13G FIlings of CorVel

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
clemons v gordon
7.74%
1,330,534
SC 13G/A
Feb 14, 2023
corstar holdings, inc.
37.3%
6,414,036
SC 13G/A
Feb 14, 2023
kayne anderson rudnick investment management llc
11.01%
1,901,500
SC 13G/A
Feb 13, 2023
renaissance technologies llc
4.33%
744,610
SC 13G/A
Feb 09, 2023
vanguard group inc
6.41%
1,106,807
SC 13G/A
Jan 25, 2023
blackrock inc.
8.7%
1,507,366
SC 13G/A
Feb 14, 2022
kayne anderson rudnick investment management llc
11.27%
1,997,505
SC 13G/A
Feb 14, 2022
clemons v gordon
7.87%
1,389,837
SC 13G/A
Feb 11, 2022
renaissance technologies llc
5.11%
902,210
SC 13G/A
Feb 10, 2022
corstar holdings, inc.
36.8%
6,494,036
SC 13G/A

CRVL Fair Value

Recent SEC filings of CorVel

View All Filings
Date Filed Form Type Document
May 16, 2023
4
Insider Trading
May 15, 2023
4
Insider Trading
May 11, 2023
4
Insider Trading
May 01, 2023
4/A
Insider Trading
Apr 28, 2023
4
Insider Trading
Apr 28, 2023
4/A
Insider Trading
Apr 28, 2023
4/A
Insider Trading
Apr 27, 2023
4
Insider Trading
Apr 06, 2023
4
Insider Trading
Apr 03, 2023
4
Insider Trading

Latest Insider Trading transactions for CRVL

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-05-12
Combs Michael G
acquired
421,440
70.24
6,000
ceo & president
2023-05-12
Combs Michael G
sold (taxes)
-862,277
219
-3,935
ceo & president
2023-05-11
JESSUP R JUDD
acquired
104,310
34.77
3,000
-
2023-05-11
JESSUP R JUDD
sold (taxes)
-104,112
216
-480
-
2023-05-10
O'Brien Brandon
acquired
116,895
77.93
1,500
chief financial officer
2023-05-10
O'Brien Brandon
sold (taxes)
-219,849
216
-1,015
chief financial officer
2023-04-27
O'Brien Brandon
sold (taxes)
-199,521
201
-989
chief financial officer
2023-04-27
O'Brien Brandon
acquired
131,535
87.69
1,500
chief financial officer
2023-04-25
Yoss Jennifer
sold (taxes)
-22,699
200
-113
vice president of accounting
2023-04-25
Yoss Jennifer
acquired
14,048
70.24
200
vice president of accounting

1–10 of 50

Michael G. Combs
3680
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.

CRVL Income Statement

2022-12-31
Consolidated Income Statements - Unaudited - USD ($)
3 Months Ended9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
REVENUES$ 179,386,000$ 164,508,000$ 533,119,000$ 474,871,000
Cost of revenues139,041,000129,320,000416,811,000365,808,000
Gross profit40,345,00035,188,000116,308,000109,063,000
General and administrative expenses18,128,00017,506,00054,347,00050,810,000
Income before income tax provision22,217,00017,682,00061,961,00058,253,000
Income tax provision5,368,0003,824,00013,765,00011,480,000
NET INCOME$ 16,849,000$ 13,858,000$ 48,196,000$ 46,773,000
Net income per common and common equivalent share    
Basic$ 0.98$ 0.78$ 2.77$ 2.62
Diluted$ 0.96$ 0.76$ 2.73$ 2.57
Weighted average common and common equivalent shares    
Basic17,245,00017,785,00017,379,00017,841,000
Diluted17,487,00018,211,00017,647,00018,221,000

CRVL Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Mar. 31, 2022
Current Assets  
Cash and cash equivalents$ 78,031,000$ 97,504,000
Customer deposits82,857,00069,781,000
Accounts receivable, net82,791,00082,586,000
Prepaid taxes and expenses13,064,00015,123,000
Total current assets256,743,000264,994,000
Property and equipment, net82,066,00076,268,000
Goodwill36,814,00036,814,000
Other intangibles, net1,350,0001,669,000
Right-of-use asset, net29,936,00035,020,000
Other assets778,000481,000
TOTAL ASSETS407,687,000415,246,000
Current Liabilities  
Accounts and taxes payable16,616,00014,431,000
Accrued liabilities169,810,000156,939,000
Total current liabilities186,426,000171,370,000
Deferred income taxes, net683,0001,689,000
Long-term lease liabilities25,773,00029,792,000
Total liabilities212,882,000202,851,000
Commitments and contingencies
Stockholders' Equity  
Common stock, $.0001 par value: 120,000,000 shares authorized at December 31, 2022 and March 31, 2022; 54,891,298 shares issued (17,180,180 shares outstanding, net of Treasury shares) and 54,788,712 shares issued (17,569,087 shares outstanding, net of Treasury shares) at December 31, 2022 and March 31, 2022, respectively3,0003,000
Paid-in capital210,904,000201,609,000
Treasury stock (37,711,118 shares at December 31, 2022 and 37,219,625 shares at March 31, 2022)(729,601,000)(654,520,000)
Retained earnings713,499,000665,303,000
Total stockholders' equity194,805,000212,395,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 407,687,000$ 415,246,000